FundingRs. 10 lakh to Rs. 30 lakh
Equity-free Idea Logistics & Mobility
ClosesJun 15, 2026
Closed Grant Equity-free
IHFC, ARTPARK, Siemens Healthineers MedTech Call for Proposals 2026
Up to Rs. 2Cr grant for startups solving 4 specific medtech problems with Siemens Healthineers.
Check your readinessShare a few details and an IncorpX advisor will walk you through fit, documents and timelines for this scheme. Free, no obligation.
- Medtech startups and academic researchers at any stage backed by IIT Delhi and Siemens Healthineers.
About this scheme
IHFC (I-Hub Foundation for Cobotics at IIT Delhi), ARTPARK (AI & Robotics Technology Park at IISc, Bengaluru), and Siemens Healthineers have issued a joint Call for Proposals targeting four specific clinical and operational challenges in medical imaging and workflow automation. This is a problem-first, industry-anchored grant , selected proposals receive funding of up to Rs. 2 crore.
The four problem statements are: wireless ECG monitoring solutions that eliminate cable interference with C-arm movement in cardiac catheterization labs; predictive navigation tools that reduce collision risk during C-arm repositioning in congested operating theatres; connected area radiation monitors for X-ray rooms that provide ambient dose tracking with centralized dashboards; and autonomous ultrasound systems that automate patient preparation, probe handling, image acquisition, and report generation.
Beyond funding, selected teams are onboarded into IHFC's Medical Cobotics Centre , a state-of-the-art facility at IIT Delhi established under the Government of India's NM-ICPS program. Teams also access ARTPARK's applied R&D infrastructure at IISc and get a direct validation pathway through Siemens Healthineers, one of the world's largest medical technology companies with operations in 180+ countries. The end goal is translational: from proposal to productization to commercialization.
The program is designed to close the gap between Indian MedTech R&D and global clinical standards, with an emphasis on domestic manufacturing and self-reliance.
Who can apply
- Open to startups and research teams working on medical devices, healthtech, and AI-driven clinical tools
- Must propose a solution addressing one of the four specific Siemens Healthineers problem statements
- Open to both registered companies and research institutions / academic teams
- No DPIIT recognition requirement disclosed
- Incorporation age and revenue thresholds not specified
Eligible entity types: Private Limited, LLP
Benefits & funding
Headline support
Up to Rs. 2 Cr
- Teams gain access to IHFC's Medical Cobotics Centre at IIT Delhi and ARTPARK's R&D infrastructure at IISc.
- Benefit from a direct validation pathway through Siemens Healthineers, supporting productization and commercialization to global clinical standards, with an emphasis on domestic manufacturing.
Official application
Ready to apply? Get the official link
Applications are submitted directly with IHFC, IIT Delhi, in your own name. Share a few details and we will point you to the official application portal and help you prepare a complete submission.
Here is the official application link
Apply in your own name with IHFC, IIT Delhi. Want a second pair of eyes before you submit? An IncorpX advisor can help you prepare.
Open the official applicationFrequently asked questions
How much funding does IHFC, ARTPARK, Siemens Healthineers MedTech Call for Proposals 2026 provide?
IHFC, ARTPARK, Siemens Healthineers MedTech Call for Proposals 2026 provides up to Rs. 2 Cr. The exact amount sanctioned depends on the proposal and the evaluation by the program authority.
Is IHFC, ARTPARK, Siemens Healthineers MedTech Call for Proposals 2026 currently accepting applications?
Closed on Apr 30, 2026. Always confirm the current window with the program authority before preparing your application.
Does IHFC, ARTPARK, Siemens Healthineers MedTech Call for Proposals 2026 take equity?
No. This program is listed as equity-free, which means the funding does not dilute your shareholding. Review the official terms for any debt or convertible components.
Important disclaimer
IncorpX is a private platform operated by a private company. It is not a government department, agency or official portal, and it is not affiliated with, endorsed by, or acting on behalf of any government body or of any organisation, incubator, accelerator, investor or partner listed in this directory. All program names, logos and trademarks are the property of their respective owners and are used for identification only.
This directory is compiled from publicly available official sources and is provided for general information only. It does not constitute legal, financial, tax or professional advice. Funding amounts, eligibility criteria, required documents, deadlines and availability are determined by each program authority and change with every cycle, so the details shown here may be incomplete or out of date. Always confirm the current terms on the official program source before you apply or take any decision.
IncorpX charges no fee for the information in this directory and does not collect, process, lodge or submit any application on your behalf. Applications are made by you, in your own name, directly with the respective program authority. IncorpX provides assistance only for application preparation and for related registrations such as company incorporation, DPIIT recognition, MSME (Udyam) and GST. Eligibility, approval, disbursement and selection rest solely with the respective program authority, and IncorpX makes no representation or guarantee as to any outcome.
Closing soon
View all FundingUp to Rs. 1 Cr
MVP / Prototype Biotech, Health & Pharma
ClosesJun 15, 2026
FundingSupport amount varies
MVP / Prototype
ClosesJun 15, 2026
Nebin Binoy 
